{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:18:16Z","timestamp":1773112696940,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00259-014-2960-y","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T14:35:27Z","timestamp":1416580527000},"page":"667-675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma"],"prefix":"10.1007","volume":"42","author":[{"given":"Egesta","family":"Lopci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Luca","family":"Ceresoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Perrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Gianoncelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gemelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"2960_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BWS Robinson","year":"2005","unstructured":"Robinson BWS, Musk AW, Lake AR. Malignant mesothelioma. Lancet. 2005;366:397\u2013408.","journal-title":"Lancet"},{"key":"2960_CR2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","volume":"117","author":"DJ Sugarbaker","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54\u201365.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2960_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004;15:257\u201360.","journal-title":"Ann Oncol"},{"key":"2960_CR4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.lungcan.2013.08.005","volume":"82","author":"SG Armato","year":"2013","unstructured":"Armato SG, Labby ZE, Coolen J, Klabatsa A, Feigen M, Persigehl T, et al. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2013;82:190\u20136.","journal-title":"Lung Cancer"},{"key":"2960_CR5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2214\/AJR.05.0076","volume":"186","author":"SG Armato III","year":"2006","unstructured":"Armato III SG, Ogarek JL, Starkey A, Vogelzang NJ, Kindler HL, Kocherginsky M, et al. Variability in mesothelioma tumor response classification. AJR Am J Roentgenol. 2006;186:1000\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"2960_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2005.12.013","volume":"52","author":"GR Oxnard","year":"2006","unstructured":"Oxnard GR, Armato III SG, Kindler HL. Modeling of mesothelioma growth demonstrates weakness of current response criteria. Lung Cancer. 2006;52:141\u20138.","journal-title":"Lung Cancer"},{"key":"2960_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ctrv.2007.07.012","volume":"33","author":"GL Ceresoli","year":"2007","unstructured":"Ceresoli GL, Chiti A, Zucali PA, Cappuzzo F, De Vincenzo F, Cavina R, et al. Assessment of tumor response in malignant pleural mesothelioma. Cancer Treat Rev. 2007;33:533\u201341.","journal-title":"Cancer Treat Rev"},{"key":"2960_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","volume":"2","author":"SM Larson","year":"1999","unstructured":"Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2:159\u201371.","journal-title":"Clin Positron Imaging"},{"key":"2960_CR9","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2006.06.8999","volume":"24","author":"GL Ceresoli","year":"2006","unstructured":"Ceresoli GL, Chiti A, Zucali PA, Rodari M, Lutman RF, Salamina S, et al. Early evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose. J Clin Oncol. 2006;24:4587\u201393.","journal-title":"J Clin Oncol"},{"key":"2960_CR10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","volume":"48","author":"RJ Francis","year":"2007","unstructured":"Francis RJ, Byrne MJ, van der Schaaf AA, Boucek JA, Nowak AK, Phillips M, et al. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med. 2007;48:1449\u201358.","journal-title":"J Nucl Med"},{"key":"2960_CR11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2009.04.015","volume":"67","author":"P Veit-Haibach","year":"2010","unstructured":"Veit-Haibach P, Schaefer NG, Steinert HC, Soyka JD, Seifert B, Stahel RA. Combined FDG-PET\/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer. 2010;67:311\u20137.","journal-title":"Lung Cancer"},{"key":"2960_CR12","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-010-1107-z","volume":"17","author":"HY Lee","year":"2010","unstructured":"Lee HY, Hyun SH, Lee KS, Kim BT, Kim J, Shim YM, et al. Volume-based parameter of 18F-FDG PET\/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol. 2010;17:2787\u201394.","journal-title":"Ann Surg Oncol"},{"key":"2960_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7150\/jca.2586","volume":"3","author":"G Genestreti","year":"2012","unstructured":"Genestreti G, Moretti A, Piciucchi S, Giovannini N, Galassi R, Scarpi E, et al. FDG PET\/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy. J Cancer. 2012;3:241\u20135.","journal-title":"J Cancer"},{"key":"2960_CR14","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ejrad.2010.11.006","volume":"81","author":"NG Schaefer","year":"2012","unstructured":"Schaefer NG, Veit-Haibach P, Soyka JD, Steinert HC, Stahel RA. Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDGPET\/CT. Eur J Radiol. 2012;81:e19\u201325.","journal-title":"Eur J Radiol"},{"key":"2960_CR15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00259-013-2561-1","volume":"41","author":"A Klabatsa","year":"2014","unstructured":"Klabatsa A, Chicklore S, Barrington S, Goh V, Lang-Lazdunski L, Cook GJ. The association of 18F-FDG PET\/CT parameters with survival in malignant pleural mesothelioma. Eur J Nucl Med Mol Imaging. 2014;41:276\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl","key":"2960_CR16","first-page":"464P","volume":"46","author":"J Boucek","year":"2005","unstructured":"Boucek J, Francis RJ, Green AJ. Automated approach to identification and quantitation of tumour volumes in chemotherapy monitoring using FDG PET [abstract]. J Nucl Med. 2005;46 Suppl:464P.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"2960_CR17","first-page":"458","volume":"55","author":"E Lopci","year":"2014","unstructured":"Lopci E, Zucali P, Giordano L, Perrino M, Ceresoli G, Gemelli M, et al. Validation of liver-based quantitative analysis on PET for response assessment in patients with malignant pleural mesothelioma. J Nucl Med. 2014;55 Suppl 1:458.","journal-title":"J Nucl Med"},{"key":"2960_CR18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"2960_CR19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/JTO.0b013e31824ab6c5","volume":"7","author":"L Lang-Lazdunski","year":"2012","unstructured":"Lang-Lazdunski L, Bille A, Lal R, Cane P, McLean E, Landau D, et al. Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol. 2012;7:737\u201343.","journal-title":"J Thorac Oncol"},{"key":"2960_CR20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01243894-200607000-00017","volume":"1","author":"P Ellis","year":"2006","unstructured":"Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline. J Thorac Oncol. 2006;1:591\u2013601.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2960_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","volume":"99","author":"GL Ceresoli","year":"2008","unstructured":"Ceresoli GL, Castagneto B, Zucali PA, Favaretto A, Mencoboni M, Grossi F, et al. Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials. Br J Cancer. 2008;99(1):51\u20136.","journal-title":"Br J Cancer"},{"key":"2960_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00130404-200311000-00008","volume":"9","author":"A Ahamad","year":"2003","unstructured":"Ahamad A, Stevens C, Smythe W, Liao Z, Vaporciyan AA, Rice D, et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J. 2003;9:476\u201384.","journal-title":"Cancer J"},{"key":"2960_CR23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/rccm.201103-0554CR","volume":"184","author":"DH Sterman","year":"2011","unstructured":"Sterman DH, Haas A, Moon E, Recio A, Schwed D, Vachani A, et al. A trial of intrapleural adenoviral-mediated interferon-alpha2b gene transfer for malignant pleural mesothelioma. Am J Respir Crit Care Med. 2011;184:1395\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2960_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/JTO.0b013e318031d05c","volume":"2","author":"M Lucchi","year":"2007","unstructured":"Lucchi M, Chella A, Melfi F, Dini P, Tibaldi C, Fontanini G, et al. Four-modality therapy in malignant pleural mesothelioma: a phase II study. J Thorac Oncol. 2007;2:237\u201342.","journal-title":"J Thorac Oncol"},{"key":"2960_CR25","doi-asserted-by":"crossref","first-page":"W215","DOI":"10.2214\/AJR.13.10572","volume":"201","author":"M Kruse","year":"2013","unstructured":"Kruse M, Sherry SJ, Paidpally V, Mercier G, Subramaniam RM. FDG PET\/CT in management of primary pleural tumors and pleural metastases. AJR Am J Roentgenol. 2013;201:W215\u201326.","journal-title":"AJR Am J Roentgenol"},{"key":"2960_CR26","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636\u201344.","journal-title":"J Clin Oncol"},{"key":"2960_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/sonc.2002.30234","volume":"29","author":"AK Nowak","year":"2002","unstructured":"Nowak AK, Lake RA, Kindler HL, Robinson BW. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol. 2002;29:82\u201396.","journal-title":"Semin Oncol"},{"key":"2960_CR28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/etm.2012.572","volume":"4","author":"T Terada","year":"2012","unstructured":"Terada T, Tabata C, Tabata R, Okuwa H, Kanemura S, Shibata E, et al. Clinical utility of 18-fluorodeoxyglucose positron emission tomography\/computed tomography in malignant pleural mesothelioma. Exp Ther Med. 2012;4:197\u2013200.","journal-title":"Exp Ther Med"},{"key":"2960_CR29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.lungcan.2013.04.024","volume":"81","author":"C Cao","year":"2013","unstructured":"Cao C, Tian DH, Pataky KA, Yan TD. Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma. Lung Cancer. 2013;81:319\u201327.","journal-title":"Lung Cancer"},{"key":"2960_CR30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","volume":"113","author":"JE Herndon","year":"1998","unstructured":"Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest. 1998;113:723\u201331.","journal-title":"Chest"},{"key":"2960_CR31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thorax.55.9.731","volume":"55","author":"JG Edwards","year":"2000","unstructured":"Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O\u2019Byrne KJ. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax. 2000;55:731\u20135.","journal-title":"Thorax"},{"key":"2960_CR32","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1158\/1078-0432.CCR-09-2313","volume":"16","author":"AK Nowak","year":"2010","unstructured":"Nowak AK, Francis RJ, Phillips MJ, Millward MJ, van der Schaaf AA, Boucek J, et al. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clin Cancer Res. 2010;16:2409\u201317.","journal-title":"Clin Cancer Res"},{"key":"2960_CR33","first-page":"1233","volume":"17","author":"A Abakay","year":"2013","unstructured":"Abakay A, Komek H, Abakay O, Palanci Y, Ekici F, Tekbas G, et al. Relationship between 18FDG PET-CT findings and survival of 177 patients with malignant pleural mesothelioma. Eur Rev Med Pharmacol Sci. 2013;17:1233\u201341.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"Suppl 1","key":"2960_CR34","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.lungcan.2005.03.006","volume":"49","author":"HC Steinert","year":"2005","unstructured":"Steinert HC, Santos Dellea MM, Burger C, Stahel R. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging. Lung Cancer. 2005;49 Suppl 1:S33\u20135.","journal-title":"Lung Cancer"},{"key":"2960_CR35","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1378\/chest.125.6.2356","volume":"125","author":"BH Kwek","year":"2004","unstructured":"Kwek BH, Auino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography after talc pleurodesis. Chest. 2004;125:2356\u201360.","journal-title":"Chest"},{"key":"2960_CR36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.lungcan.2007.05.015","volume":"58","author":"H Ahmadzadehfar","year":"2007","unstructured":"Ahmadzadehfar H, Palmedo H, Strunk H, Biersack HJ, Habibi E, Ezziddin S. False positive 18F-FDG-PET\/CT in a patient after talc pleurodesis. Lung Cancer. 2007;58:418\u201321.","journal-title":"Lung Cancer"},{"key":"2960_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2010.05.016","volume":"70","author":"AK Novak","year":"2010","unstructured":"Novak AK, Armato SG, Ceresoli GL, Yildirim H, Francis RJ. Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group. Lung Cancer. 2010;70:1\u20136.","journal-title":"Lung Cancer"},{"issue":"Suppl 13","key":"2960_CR38","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1007\/s00259-006-0133-3","volume":"33","author":"WA Weber","year":"2006","unstructured":"Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging. 2006;33 Suppl 13:S27\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2960_CR39","first-page":"167","volume":"53","author":"G Strorto","year":"2009","unstructured":"Strorto G, Nicolai E, Salvatore M. [18F]FDG-PET\/CT for early monitoring of tumor response: when and why. Q J Nucl Med Mol Imaging. 2009;53:167\u201380.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2960_CR40","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","volume":"35","author":"H Young","year":"1999","unstructured":"Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer. 1999;35:1773\u201382.","journal-title":"Eur J Cancer"},{"key":"2960_CR41","doi-asserted-by":"crossref","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S\u201350.","DOI":"10.2967\/jnumed.108.057307"},{"key":"2960_CR42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","volume":"16","author":"D Curran","year":"1998","unstructured":"Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol. 1998;16:145\u201352.","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-014-2960-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2960-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T17:47:18Z","timestamp":1566064038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-014-2960-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["2960"],"URL":"https:\/\/doi.org\/10.1007\/s00259-014-2960-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]}}}